标普和纳斯达克内在价值 联系我们

Intelligent Bio Solutions Inc. INBS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Diagnostics & Research • US • USD

SharesGrow Score
29/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Intelligent Bio Solutions Inc. (INBS) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.

分析师预估 每股收益(EPS)为 $-36.70 和 营收为 $0.00B (下一财年).

每股收益(EPS)历史表现: 2024: 实际 $-6.38 vs 预期 $-36.70 (超预期 +82.6%). 2025: 实际 $-20.00 vs 预期 $-12.50 (不及预期 -60%). 分析师准确度: 0%.

EPS 预测 — INBS

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$6.38 vs Est –$36.70 ▲ 475.2% off
2025 Actual –$20.00 vs Est –$12.50 ▼ 37.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

营收预测 — INBS

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $0.003B vs Est $0.004B ▼ 35.0% off
2025 Actual $0.003B vs Est $0.012B ▼ 280.0% off
Revenue Trend
Revenue has been relatively flat. Analysts forecast significant revenue growth ahead.
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言